MX2022002420A - Metodos de tratamiento de trastorno de espectro autista. - Google Patents

Metodos de tratamiento de trastorno de espectro autista.

Info

Publication number
MX2022002420A
MX2022002420A MX2022002420A MX2022002420A MX2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A
Authority
MX
Mexico
Prior art keywords
vafidemstat
autism spectrum
spectrum disorders
treating autism
treating
Prior art date
Application number
MX2022002420A
Other languages
English (en)
Inventor
Arjol Carlos Manuel Buesa
Quiroga José Antonio Ramos
Roger Alan Bullock
Original Assignee
Oryzon Genomics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryzon Genomics Sa filed Critical Oryzon Genomics Sa
Publication of MX2022002420A publication Critical patent/MX2022002420A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Se proporcionan en la presente métodos para tratar trastorno de espectro autista usando vafidemstat.
MX2022002420A 2019-09-03 2020-09-03 Metodos de tratamiento de trastorno de espectro autista. MX2022002420A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382751 2019-09-03
EP19382855 2019-10-03
PCT/EP2020/074602 WO2021043905A1 (en) 2019-09-03 2020-09-03 Vafidemstat for use in treating autism spectrum disorders

Publications (1)

Publication Number Publication Date
MX2022002420A true MX2022002420A (es) 2022-05-06

Family

ID=72266308

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002420A MX2022002420A (es) 2019-09-03 2020-09-03 Metodos de tratamiento de trastorno de espectro autista.

Country Status (6)

Country Link
US (2) US20220288039A1 (es)
EP (1) EP4025210A1 (es)
JP (1) JP2022546134A (es)
CN (1) CN114615979A (es)
MX (1) MX2022002420A (es)
WO (1) WO2021043905A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO2012013728A1 (en) 2010-07-29 2012-02-02 Oryzon Genomics S.A. Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
CA3071804A1 (en) * 2017-08-03 2019-02-07 Oryzon Genomics, S.A. Methods of treating behavior alterations

Also Published As

Publication number Publication date
JP2022546134A (ja) 2022-11-02
US20220288039A1 (en) 2022-09-15
WO2021043905A1 (en) 2021-03-11
CN114615979A (zh) 2022-06-10
EP4025210A1 (en) 2022-07-13
US20240226069A1 (en) 2024-07-11

Similar Documents

Publication Publication Date Title
CA193736S (en) Skin massager
MX2021010193A (es) Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales.
MY192571A (en) Treatment installation and method for treating workpieces
MX2018000778A (es) Metodos para tratar trastornos mediados por hepcidinas.
SG11202009371WA (en) Methods for treating atopic dermatitis by administering an il-4r inhibitor
MX2020008195A (es) Compuestos para el tratamiento del dolor.
AU2018337076A1 (en) Method of treatment
PH12020552059A1 (en) Dosing regimen for the treatment of pi3k related disorders
TN2019000210A1 (en) Antitumoral compounds
EP4182805A4 (en) DATABASE SESSIONS THAT CAN BE ATTACHED AND DETACHED
MX2023008193A (es) Procedimientos para tratar el cáncer.
EP3773491A4 (en) METHODS OF TREATMENT FOR APOE4 / 4-ASSOCIATED DISEASES
PH12019501678A1 (en) Potassium channel modulators
ZA202108429B (en) Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
IL286126A (en) Formulations for the treatment of cluster symptoms associated with autism spectrum disorder
MX2022004910A (es) Metodos de tratamiento de los sintomas del trastorno del espectro autista.
MX2022002420A (es) Metodos de tratamiento de trastorno de espectro autista.
MX2021009670A (es) Tratamiento para el cancer.
MX2020012964A (es) Metodos para el tratamiento de cancer de vejiga.
MX2022013883A (es) Compuestos de metiltioninio para uso en el tratamiento de covid-19.
MX2018015464A (es) Uso de benzoato de litio para tratar trastornos del sistema nervioso central.
MX2021011256A (es) Metodos de tratamiento del trastorno limite de la personalidad.
EP4043013A4 (en) METHOD FOR TREATING AFFECTIVE DISORDERS
MX2021011254A (es) Metodos de tratamiento del trastorno por deficit de atencion e hiperactividad.
SG11202111960PA (en) Method for treating endometriosis-associated pain by using diaminopyrimidine compound